首页 | 本学科首页   官方微博 | 高级检索  
     

信必可都保和舒利迭治疗支气管哮喘的疗效对比
引用本文:罗虹. 信必可都保和舒利迭治疗支气管哮喘的疗效对比[J]. 中西医结合研究, 2010, 2(1): 11-14
作者姓名:罗虹
作者单位:四川省人民医院保健科,成都,610072
摘    要:目的评价信必可都保和舒利迭在治疗轻、中度支气管哮喘的临床疗效及安全性,并对二者的疗效加以比较。方法将80例支气管哮喘患者随机分为信必可都保组和舒利迭组,比较两组治疗前后的临床疗效和肺功能。结果经治疗两组患者的哮喘症状均得到改善,但信必可都保组症状改善更显著(P0.05);在肺功能方面,两组患者第1秒用力呼气量(FEV1)都有所提高,两组间比较差异无统计学意义,但信必可都保组对晨间呼气峰流速(PEF)提高较舒利迭组显著(P0.05),两组不良事件的发生率无差异(P0.05)。结论信必可都保和舒利迭对支气管哮喘的症状和肺功能都有良好的改善作用,但信必可都保起效时间更快。

关 键 词:信必可都保  舒利迭  支气管哮喘  肺功能  疗效

The Comparison of Effect of Symbicort Turbuhaler and Seretide in the Treatment of Patients with Bronchial Asthma
LUO Hong. The Comparison of Effect of Symbicort Turbuhaler and Seretide in the Treatment of Patients with Bronchial Asthma[J]. Rsearch of Integrated Traditional Chinese and Western Medicine, 2010, 2(1): 11-14
Authors:LUO Hong
Affiliation:LUO Hong Department of Health Care,Sichuan Province People's Hospital,Chengdu 610072
Abstract:Objective To evaluate the effect and safety between Symbicort Turbuhaler and Seretide in the treatment of patients with bronchial asthma and compare the curative effect.Methods Trabant comparative study was conducted to compare the clinical effect and safety of Symbicort Turbuhaler and Seretide in the treatment of 80 patients with bronchial asthma,40 patients received Symbicort Turbuhaler and the others received Seretide,the clinical symptoms,lung function and adverse events were observed.Results Improvemen...
Keywords:Symbicort Turbuhaler  Seretide  Bronchial asthma  Lung function  Efficacy  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号